摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methyl-3-[4-[1-(2-pyrimidyl)-4-piperazinyl]butyl]-4-thiazolidinone maleate | 124468-35-5

中文名称
——
中文别名
——
英文名称
2-Methyl-3-[4-[1-(2-pyrimidyl)-4-piperazinyl]butyl]-4-thiazolidinone maleate
英文别名
(Z)-but-2-enedioic acid;2-methyl-3-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,3-thiazolidin-4-one
2-Methyl-3-[4-[1-(2-pyrimidyl)-4-piperazinyl]butyl]-4-thiazolidinone maleate化学式
CAS
124468-35-5
化学式
C4H4O4*C16H25N5OS
mdl
——
分子量
451.547
InChiKey
JNTOINWDRKBXTB-BTJKTKAUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.01
  • 重原子数:
    31
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    153
  • 氢给体数:
    2
  • 氢受体数:
    10

反应信息

点击查看最新优质反应信息

文献信息

  • 3-[4-(1-substituted-4-piperazinyl)butyl]-4-thiazolidinone and related
    申请人:Hoechst-Roussel Pharmaceuticals Incorporated
    公开号:US05229388A1
    公开(公告)日:1993-07-20
    There are disclosed compounds of the formula, ##STR1## where n is 0, 1 or 2; A is ##STR2## where X in each occurrence is independently hydrogen, halogen, loweralkyl, hydroxy, nitro, loweralkoxy, amino, cyano, trifluoromethyl or methylthio; Y in each occurrence is independently hydrogen, halogen, loweralkyl, hydroxy, nitro, loweralkoxy, amino, cyano, trifluoromethyl or methylthio; m is 1 or 2; k is 1 or 2; R.sub.1 and R.sub.2 are independently hydrogen, loweralkyl, ##STR3## or aryl except that when R.sub.1 is ##STR4## or aryl, R.sub.2 is hydrogen, or alternatively R.sub.1 +R.sub.2 taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane, cycloheptane, pyran, thiopyran, indan or piperidine ring; R.sub.3 and R.sub.4 are independently hydrogen or loweralkyl, or alternatively R.sub.3 +R.sub.4 taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane, cycloheptane, pyran, thiopyran, pyrrolidine or piperidine ring, the term aryl signifying an unsubstituted phenyl group or a phenyl group substituted with 1, 2 or 3 substituents each of which being independently loweralkyl, loweralkoxy, hydroxy, halogen, loweralkylthio, cyano, amino or trifluoromethyl, which are useful as antipsychotic, analgesic, anticonvulsant and anxiolytic agents.
    公式中披露了化合物,其中n为0、1或2;A为其中X在每次出现时独立地为氢、卤素、较低烷基、羟基、硝基、较低烷氧基、基、基、三甲基或甲基;Y在每次出现时独立地为氢、卤素、较低烷基、羟基、硝基、较低烷氧基、基、基、三甲基或甲基;m为1或2;k为1或2;R.sub.1和R.sub.2独立地为氢、较低烷基、或芳基,但当R.sub.1为或芳基时,R.sub.2为氢,或者R.sub.1 +R.sub.2与它们附着的碳原子一起形成环戊烷环己烷环庚烷喃、喃、哌啶环;R.sub.3和R.sub.4独立地为氢或较低烷基,或者R.sub.3 +R.sub.4与它们附着的碳原子一起形成环戊烷环己烷环庚烷喃、喃、吡咯烷或哌啶环,术语芳基表示未取代的苯基或一个苯基,其上取代基为1、2或3个,每个取代基独立地为较低烷基、较低烷氧基、羟基、卤素、较低烷基、基、基或三甲基,这些化合物可用作抗精神病、镇痛、抗癫痫和抗焦虑药物。
  • 3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments
    申请人:HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED
    公开号:EP0316723A1
    公开(公告)日:1989-05-24
    There are disclosed compounds of the formula, where n is 0̸ or 1; A is where X, Y, Z, U, V, W, Q, S and T are each hydrogen, halogen, loweralkyl, hydroxy, nitro, loweralkoxy, amino, cyano or trifluoromethyl; m is 1 or 2; R₁ and R₂ are independently hydrogen, loweralkyl or aryl, or alternatively R₁ + R₂ taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane, cycloheptane, pyran, thiopyran, pyrrolidine or piperidine ring; R₃ and R₄ are independently hydrogen or loweralkyl, or alternatively R₃ + R₄ taken together with the carbon atom to which they are attached form a cyclopentane, cyclohexane, cycloheptane, pyran, thiopyran, pyrrolidine or piperidine ring, the term aryl signifying an unsubstituted phenyl group or a phenyl group substituted with 1, 2 or 3 substituents each of which being independently loweralkyl, loweralkoxy, hydroxy, halogen, loweralkylthio, cyano, amino or trifluormethyl, and a process for their preparation. The compounds are useful as antipsychotic, analgesic, anticonvulsant and anxiolytic agents.
    公开了如下式的化合物 其中 n 是 0̸ 或 1;A 是 其中 X、Y、Z、U、V、W、Q、S 和 T 各为氢、卤素、低级烷基、羟基、硝基、低级烷氧基、基、基或三甲基;m 为 1 或 2;R₁ 和 R₂ 独立地为氢、低级烷基或芳基,或者 R₁ + R₂ 与它们所连接的碳原子一起形成环戊烷环己烷环庚烷喃、喃、吡咯烷或哌啶环;R₃ 和 R₄ 独立地为氢或低级烷基,或者 R₃ + R₄ 与所连接的碳原子一起形成环戊烷环己烷环庚烷喃、喃、吡咯烷或哌啶环、芳基是指未取代的苯基或被 1、2 或 3 个取代基取代的苯基,每个取代基都是独立的低级烷基、低级烷氧基、羟基、卤素、低级烷基、基、基或三甲基,以及它们的制备方法。这些化合物可用作抗精神病药镇痛药、抗惊厥药和抗焦虑药
  • US4933453A
    申请人:——
    公开号:US4933453A
    公开(公告)日:1990-06-12
  • US5037984A
    申请人:——
    公开号:US5037984A
    公开(公告)日:1991-08-06
  • US5136037A
    申请人:——
    公开号:US5136037A
    公开(公告)日:1992-08-04
查看更多